Muhammad Ar Bhuyan, Mamun Al Mahtab, Eshita Ashab, Md Jahirul Haque, Syed Md M Hoque, Akm Faizul Huq, Md Atikul Islam, Nuzhat Choudhury, Reema A Alia, Musarrat Mahtab, Md Sakirul I Khan, Sheikh Mf Akbar
{"title":"孟加拉国一所医学院医院对COVID-19患者的治疗。","authors":"Muhammad Ar Bhuyan, Mamun Al Mahtab, Eshita Ashab, Md Jahirul Haque, Syed Md M Hoque, Akm Faizul Huq, Md Atikul Islam, Nuzhat Choudhury, Reema A Alia, Musarrat Mahtab, Md Sakirul I Khan, Sheikh Mf Akbar","doi":"10.5005/jp-journals-10018-1317","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has induced a sense of panic around the world as the disease is highly contagious and has been spreading in full swing during last 5 months causing millions of COVID-19 patients and hundreds of thousands of deaths. Bangladesh, a country of 170 million people, is not an exception regarding COVID-19; it has reported several thousand COVID-19 patients with several hundred of deaths. This observational study has been planned to assess the scope and limitation of management strategy against COVID-19 patients in a medical college hospital of Bangladesh with available drugs in a real-life situation.</p><p><strong>Materials and methods: </strong>All patients in this cohort (<i>N</i>: 33) were positive for SARS-CoV-2 by polymerase chain reaction (PCR) and they attended the hospital with variable presenting symptoms those ranged from cough and fever to respiratory distress and pneumonia. As per the protocol, the patients were regularly evaluated for several parameters of COVID-19-related pathology. Before discharge, they were checked for SARS-CoV-2 for 2 consecutive times. The management strategy included standard of care (SoC) and administration of hydroxychloroquine and azythromycin, available in Bangladesh.</p><p><strong>Results: </strong>Out of total 33 patients, 1 patient died at day 4 day after admission. Two patients developed severe complications and were referred to tertiary hospital in Dhaka (2 and 3 days after admission), the capital of Bangladesh, where they recovered and were discharged from hospital after being SARS-CoV-2 negative. The rest 30 patients were discharged from the medical college hospital after being negative for SARS-CoV-2 in two subsequent assessments and improvement of their COVID-related symptoms. The average hospital stay of these patients was 14.5 days with a range of 10-24 days.</p><p><strong>Conclusion: </strong>It seems that most of the COVID-19 patients may be adequately managed by standard of care management with drug support. However, early diagnosis and hospitalization with adequate care may be important variables for better survival. These factors may be properly ensured if the patient burden remains at a palatable level in forthcoming days in Bangladesh.</p><p><strong>How to cite this article: </strong>Bhuyan MAR, Al Mahtab M, Ashab E, <i>et al.</i> Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh. Euroasian J Hepato-Gastroenterol 2020;10(1):27-30.</p>","PeriodicalId":11992,"journal":{"name":"Euroasian Journal of Hepato-Gastroenterology","volume":"10 1","pages":"27-30"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/15/ejohg-10-27.PMC7376594.pdf","citationCount":"24","resultStr":"{\"title\":\"Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh.\",\"authors\":\"Muhammad Ar Bhuyan, Mamun Al Mahtab, Eshita Ashab, Md Jahirul Haque, Syed Md M Hoque, Akm Faizul Huq, Md Atikul Islam, Nuzhat Choudhury, Reema A Alia, Musarrat Mahtab, Md Sakirul I Khan, Sheikh Mf Akbar\",\"doi\":\"10.5005/jp-journals-10018-1317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and aim: </strong>Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has induced a sense of panic around the world as the disease is highly contagious and has been spreading in full swing during last 5 months causing millions of COVID-19 patients and hundreds of thousands of deaths. Bangladesh, a country of 170 million people, is not an exception regarding COVID-19; it has reported several thousand COVID-19 patients with several hundred of deaths. This observational study has been planned to assess the scope and limitation of management strategy against COVID-19 patients in a medical college hospital of Bangladesh with available drugs in a real-life situation.</p><p><strong>Materials and methods: </strong>All patients in this cohort (<i>N</i>: 33) were positive for SARS-CoV-2 by polymerase chain reaction (PCR) and they attended the hospital with variable presenting symptoms those ranged from cough and fever to respiratory distress and pneumonia. As per the protocol, the patients were regularly evaluated for several parameters of COVID-19-related pathology. Before discharge, they were checked for SARS-CoV-2 for 2 consecutive times. The management strategy included standard of care (SoC) and administration of hydroxychloroquine and azythromycin, available in Bangladesh.</p><p><strong>Results: </strong>Out of total 33 patients, 1 patient died at day 4 day after admission. Two patients developed severe complications and were referred to tertiary hospital in Dhaka (2 and 3 days after admission), the capital of Bangladesh, where they recovered and were discharged from hospital after being SARS-CoV-2 negative. The rest 30 patients were discharged from the medical college hospital after being negative for SARS-CoV-2 in two subsequent assessments and improvement of their COVID-related symptoms. The average hospital stay of these patients was 14.5 days with a range of 10-24 days.</p><p><strong>Conclusion: </strong>It seems that most of the COVID-19 patients may be adequately managed by standard of care management with drug support. However, early diagnosis and hospitalization with adequate care may be important variables for better survival. These factors may be properly ensured if the patient burden remains at a palatable level in forthcoming days in Bangladesh.</p><p><strong>How to cite this article: </strong>Bhuyan MAR, Al Mahtab M, Ashab E, <i>et al.</i> Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh. Euroasian J Hepato-Gastroenterol 2020;10(1):27-30.</p>\",\"PeriodicalId\":11992,\"journal\":{\"name\":\"Euroasian Journal of Hepato-Gastroenterology\",\"volume\":\"10 1\",\"pages\":\"27-30\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1b/15/ejohg-10-27.PMC7376594.pdf\",\"citationCount\":\"24\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Euroasian Journal of Hepato-Gastroenterology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5005/jp-journals-10018-1317\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Euroasian Journal of Hepato-Gastroenterology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10018-1317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 24
摘要
背景与目的:由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引起的冠状病毒病2019 (COVID-19)在全球引起了恐慌,因为这种疾病具有高度传染性,在过去5个月里一直在全面蔓延,导致数百万患者和数十万人死亡。拥有1.7亿人口的孟加拉国也不例外。它已经报告了数千名COVID-19患者,其中数百人死亡。本观察性研究计划评估孟加拉国一所医学院医院在现实生活中有可用药物的COVID-19患者管理策略的范围和局限性。材料和方法:本队列患者(N: 33)均为SARS-CoV-2聚合酶链反应(PCR)阳性,并以咳嗽、发热、呼吸窘迫和肺炎等不同症状就诊。根据方案,定期对患者进行covid -19相关病理的多项参数评估。出院前连续2次进行SARS-CoV-2检测。管理策略包括护理标准(SoC)以及在孟加拉国提供的羟氯喹和阿奇霉素的管理。结果:33例患者中,1例患者在入院后第4天死亡。两名患者出现严重并发症,并被转诊到孟加拉国首都达卡的三级医院(入院后2天和3天),在那里他们康复并在SARS-CoV-2阴性后出院。其余30例患者经2次后续评估SARS-CoV-2阴性,症状好转后出院。这些患者的平均住院时间为14.5天,10-24天不等。结论:大多数新冠肺炎患者似乎可以通过标准护理管理和药物支持得到充分的管理。然而,早期诊断和住院治疗是提高生存率的重要因素。如果孟加拉国今后几天的患者负担保持在可接受的水平,就可以适当地确保这些因素。如何引用本文:Bhuyan MAR, Al Mahtab M, Ashab E,等。孟加拉国一所医学院医院对COVID-19患者的治疗。中华肝病与胃肠病杂志2020;10(1):27-30。
Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh.
Background and aim: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has induced a sense of panic around the world as the disease is highly contagious and has been spreading in full swing during last 5 months causing millions of COVID-19 patients and hundreds of thousands of deaths. Bangladesh, a country of 170 million people, is not an exception regarding COVID-19; it has reported several thousand COVID-19 patients with several hundred of deaths. This observational study has been planned to assess the scope and limitation of management strategy against COVID-19 patients in a medical college hospital of Bangladesh with available drugs in a real-life situation.
Materials and methods: All patients in this cohort (N: 33) were positive for SARS-CoV-2 by polymerase chain reaction (PCR) and they attended the hospital with variable presenting symptoms those ranged from cough and fever to respiratory distress and pneumonia. As per the protocol, the patients were regularly evaluated for several parameters of COVID-19-related pathology. Before discharge, they were checked for SARS-CoV-2 for 2 consecutive times. The management strategy included standard of care (SoC) and administration of hydroxychloroquine and azythromycin, available in Bangladesh.
Results: Out of total 33 patients, 1 patient died at day 4 day after admission. Two patients developed severe complications and were referred to tertiary hospital in Dhaka (2 and 3 days after admission), the capital of Bangladesh, where they recovered and were discharged from hospital after being SARS-CoV-2 negative. The rest 30 patients were discharged from the medical college hospital after being negative for SARS-CoV-2 in two subsequent assessments and improvement of their COVID-related symptoms. The average hospital stay of these patients was 14.5 days with a range of 10-24 days.
Conclusion: It seems that most of the COVID-19 patients may be adequately managed by standard of care management with drug support. However, early diagnosis and hospitalization with adequate care may be important variables for better survival. These factors may be properly ensured if the patient burden remains at a palatable level in forthcoming days in Bangladesh.
How to cite this article: Bhuyan MAR, Al Mahtab M, Ashab E, et al. Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh. Euroasian J Hepato-Gastroenterol 2020;10(1):27-30.